Abstract
Summary
Multivitamin tablets are additional supplement products available in the form of tablets that are consumed to make-up for the necessary vitamins which cannot be consumed through a conventional diet. These supplements are consumed for treatment of various deficiencies relating to nutrition and health in humans. It is highly essential for pregnant women as they require consuming a variety of nutritional components for the foetus as well.
The global market for Multivitamin Tablet was estimated to be worth US$ 390.2 million in 2023 and is forecast to a readjusted size of US$ 521.8 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
North American market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Multivitamin Tablet include Amway, Abbott, Bayer, Arkopharma, Pfizer, Nature's Bounty, Herbalife International of America, Bionova and American Health, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multivitamin Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multivitamin Tablet by region & country, by Type, and by Application.
The Multivitamin Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multivitamin Tablet.
Market Segmentation
By Company
Amway
Abbott
Bayer
Arkopharma
Pfizer
Nature's Bounty
Herbalife International of America
Bionova
American Health
Sona
Dwarkesh Pharmaceuticals
Saillon Pharma
21ST Century HealthCare
V.Excel International
Segment by Type:
OTC
Prescribed
Segment by Application
Energy and Weight Management
Bone and Joint Health
Gastrointestinal Health
Cardiac Health
Diabetes
Anti-cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Multivitamin Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Multivitamin Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Multivitamin Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Multivitamin Tablet was estimated to be worth US$ 390.2 million in 2023 and is forecast to a readjusted size of US$ 521.8 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
North American market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Multivitamin Tablet was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Multivitamin Tablet include Amway, Abbott, Bayer, Arkopharma, Pfizer, Nature's Bounty, Herbalife International of America, Bionova and American Health, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multivitamin Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multivitamin Tablet by region & country, by Type, and by Application.
The Multivitamin Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multivitamin Tablet.
Market Segmentation
By Company
Amway
Abbott
Bayer
Arkopharma
Pfizer
Nature's Bounty
Herbalife International of America
Bionova
American Health
Sona
Dwarkesh Pharmaceuticals
Saillon Pharma
21ST Century HealthCare
V.Excel International
Segment by Type:
OTC
Prescribed
Segment by Application
Energy and Weight Management
Bone and Joint Health
Gastrointestinal Health
Cardiac Health
Diabetes
Anti-cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Multivitamin Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Multivitamin Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Multivitamin Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Multivitamin Tablet Product Introduction
1.2 Global Multivitamin Tablet Market Size Forecast
1.2.1 Global Multivitamin Tablet Sales Value (2019-2030)
1.2.2 Global Multivitamin Tablet Sales Volume (2019-2030)
1.2.3 Global Multivitamin Tablet Sales Price (2019-2030)
1.3 Multivitamin Tablet Market Trends & Drivers
1.3.1 Multivitamin Tablet Industry Trends
1.3.2 Multivitamin Tablet Market Drivers & Opportunity
1.3.3 Multivitamin Tablet Market Challenges
1.3.4 Multivitamin Tablet Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Multivitamin Tablet Players Revenue Ranking (2023)
2.2 Global Multivitamin Tablet Revenue by Company (2019-2024)
2.3 Global Multivitamin Tablet Players Sales Volume Ranking (2023)
2.4 Global Multivitamin Tablet Sales Volume by Company Players (2019-2024)
2.5 Global Multivitamin Tablet Average Price by Company (2019-2024)
2.6 Key Manufacturers Multivitamin Tablet Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Multivitamin Tablet Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Multivitamin Tablet
2.9 Multivitamin Tablet Market Competitive Analysis
2.9.1 Multivitamin Tablet Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Multivitamin Tablet Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multivitamin Tablet as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 OTC
3.1.2 Prescribed
3.2 Global Multivitamin Tablet Sales Value by Type
3.2.1 Global Multivitamin Tablet Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Multivitamin Tablet Sales Value, by Type (2019-2030)
3.2.3 Global Multivitamin Tablet Sales Value, by Type (%) (2019-2030)
3.3 Global Multivitamin Tablet Sales Volume by Type
3.3.1 Global Multivitamin Tablet Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Multivitamin Tablet Sales Volume, by Type (2019-2030)
3.3.3 Global Multivitamin Tablet Sales Volume, by Type (%) (2019-2030)
3.4 Global Multivitamin Tablet Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Energy and Weight Management
4.1.2 Bone and Joint Health
4.1.3 Gastrointestinal Health
4.1.4 Cardiac Health
4.1.5 Diabetes
4.1.6 Anti-cancer
4.1.7 Others
4.2 Global Multivitamin Tablet Sales Value by Application
4.2.1 Global Multivitamin Tablet Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Multivitamin Tablet Sales Value, by Application (2019-2030)
4.2.3 Global Multivitamin Tablet Sales Value, by Application (%) (2019-2030)
4.3 Global Multivitamin Tablet Sales Volume by Application
4.3.1 Global Multivitamin Tablet Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Multivitamin Tablet Sales Volume, by Application (2019-2030)
4.3.3 Global Multivitamin Tablet Sales Volume, by Application (%) (2019-2030)
4.4 Global Multivitamin Tablet Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Multivitamin Tablet Sales Value by Region
5.1.1 Global Multivitamin Tablet Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Multivitamin Tablet Sales Value by Region (2019-2024)
5.1.3 Global Multivitamin Tablet Sales Value by Region (2025-2030)
5.1.4 Global Multivitamin Tablet Sales Value by Region (%), (2019-2030)
5.2 Global Multivitamin Tablet Sales Volume by Region
5.2.1 Global Multivitamin Tablet Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Multivitamin Tablet Sales Volume by Region (2019-2024)
5.2.3 Global Multivitamin Tablet Sales Volume by Region (2025-2030)
5.2.4 Global Multivitamin Tablet Sales Volume by Region (%), (2019-2030)
5.3 Global Multivitamin Tablet Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Multivitamin Tablet Sales Value, 2019-2030
5.4.2 North America Multivitamin Tablet Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Multivitamin Tablet Sales Value, 2019-2030
5.5.2 Europe Multivitamin Tablet Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Multivitamin Tablet Sales Value, 2019-2030
5.6.2 Asia Pacific Multivitamin Tablet Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Multivitamin Tablet Sales Value, 2019-2030
5.7.2 South America Multivitamin Tablet Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Multivitamin Tablet Sales Value, 2019-2030
5.8.2 Middle East & Africa Multivitamin Tablet Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Multivitamin Tablet Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Multivitamin Tablet Sales Value
6.2.1 Key Countries/Regions Multivitamin Tablet Sales Value, 2019-2030
6.2.2 Key Countries/Regions Multivitamin Tablet Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Multivitamin Tablet Sales Value, 2019-2030
6.3.2 United States Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Multivitamin Tablet Sales Value, 2019-2030
6.4.2 Europe Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Multivitamin Tablet Sales Value, 2019-2030
6.5.2 China Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.5.3 China Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Multivitamin Tablet Sales Value, 2019-2030
6.6.2 Japan Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Multivitamin Tablet Sales Value, 2019-2030
6.7.2 South Korea Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Multivitamin Tablet Sales Value, 2019-2030
6.8.2 Southeast Asia Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Multivitamin Tablet Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Multivitamin Tablet Sales Value, 2019-2030
6.9.2 India Multivitamin Tablet Sales Value by Type (%), 2023 VS 2030
6.9.3 India Multivitamin Tablet Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amway
7.1.1 Amway Company Information
7.1.2 Amway Introduction and Business Overview
7.1.3 Amway Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Amway Multivitamin Tablet Product Offerings
7.1.5 Amway Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Multivitamin Tablet Product Offerings
7.2.5 Abbott Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Introduction and Business Overview
7.3.3 Bayer Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bayer Multivitamin Tablet Product Offerings
7.3.5 Bayer Recent Development
7.4 Arkopharma
7.4.1 Arkopharma Company Information
7.4.2 Arkopharma Introduction and Business Overview
7.4.3 Arkopharma Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Arkopharma Multivitamin Tablet Product Offerings
7.4.5 Arkopharma Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Information
7.5.2 Pfizer Introduction and Business Overview
7.5.3 Pfizer Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Multivitamin Tablet Product Offerings
7.5.5 Pfizer Recent Development
7.6 Nature's Bounty
7.6.1 Nature's Bounty Company Information
7.6.2 Nature's Bounty Introduction and Business Overview
7.6.3 Nature's Bounty Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nature's Bounty Multivitamin Tablet Product Offerings
7.6.5 Nature's Bounty Recent Development
7.7 Herbalife International of America
7.7.1 Herbalife International of America Company Information
7.7.2 Herbalife International of America Introduction and Business Overview
7.7.3 Herbalife International of America Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Herbalife International of America Multivitamin Tablet Product Offerings
7.7.5 Herbalife International of America Recent Development
7.8 Bionova
7.8.1 Bionova Company Information
7.8.2 Bionova Introduction and Business Overview
7.8.3 Bionova Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bionova Multivitamin Tablet Product Offerings
7.8.5 Bionova Recent Development
7.9 American Health
7.9.1 American Health Company Information
7.9.2 American Health Introduction and Business Overview
7.9.3 American Health Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.9.4 American Health Multivitamin Tablet Product Offerings
7.9.5 American Health Recent Development
7.10 Sona
7.10.1 Sona Company Information
7.10.2 Sona Introduction and Business Overview
7.10.3 Sona Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sona Multivitamin Tablet Product Offerings
7.10.5 Sona Recent Development
7.11 Dwarkesh Pharmaceuticals
7.11.1 Dwarkesh Pharmaceuticals Company Information
7.11.2 Dwarkesh Pharmaceuticals Introduction and Business Overview
7.11.3 Dwarkesh Pharmaceuticals Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Dwarkesh Pharmaceuticals Multivitamin Tablet Product Offerings
7.11.5 Dwarkesh Pharmaceuticals Recent Development
7.12 Saillon Pharma
7.12.1 Saillon Pharma Company Information
7.12.2 Saillon Pharma Introduction and Business Overview
7.12.3 Saillon Pharma Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Saillon Pharma Multivitamin Tablet Product Offerings
7.12.5 Saillon Pharma Recent Development
7.13 21ST Century HealthCare
7.13.1 21ST Century HealthCare Company Information
7.13.2 21ST Century HealthCare Introduction and Business Overview
7.13.3 21ST Century HealthCare Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.13.4 21ST Century HealthCare Multivitamin Tablet Product Offerings
7.13.5 21ST Century HealthCare Recent Development
7.14 V.Excel International
7.14.1 V.Excel International Company Information
7.14.2 V.Excel International Introduction and Business Overview
7.14.3 V.Excel International Multivitamin Tablet Sales, Revenue and Gross Margin (2019-2024)
7.14.4 V.Excel International Multivitamin Tablet Product Offerings
7.14.5 V.Excel International Recent Development
8 Industry Chain Analysis
8.1 Multivitamin Tablet Industrial Chain
8.2 Multivitamin Tablet Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Multivitamin Tablet Sales Model
8.5.2 Sales Channel
8.5.3 Multivitamin Tablet Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer